(Press-News.org) INDIANAPOLIS -- People with muscular dystrophy could one day assess the effectiveness of their medication with the help of a smartphone-linked device, a new study in mice suggests. The study used a new method to process ultrasound imaging information that could lead to hand-held instruments that provide fast, convenient medical information.
In the study presented Oct. 30 at the Acoustical Society of America's annual meeting, researchers determined how well muscles damaged by muscular dystrophy responded to a drug in mice with an animal form of the disease. They did so by processing ultrasound data in a way appropriate for small, low-power and relatively inexpensive instruments. Called point-of-care devices, such instruments allow physicians to bring healthcare to the patient.
Physicist Michael S. Hughes of the Department of Energy's Pacific Northwest National Laboratory performed the work with colleagues John E. McCarthy, Jon N. Marsh, and Samuel A. Wickline while at Washington University in St. Louis, Missouri.
Although a small study involving animals, it builds on work in people that shows noninvasive ultrasound can track muscle health. Duchenne muscular dystrophy -- often shortened to DMD -- affects one out of 3500 male births. Steroids can help slow muscle degeneration, but too much medication causes other issues such as weight gain and high blood pressure.
"The result implies you can monitor drug therapy with cheap point-of-care devices," said Hughes. "We'd like to be able to use low-power handheld instruments, such as a microphone-sized ultrasound that can fit on a smartphone."
Healthcare workers and patients want fast, easy-to-use medical instruments and diagnostic tests that they can bring to a patient's bedside, home or to the field. Some treatments for disease require constant monitoring, such as blood glucose in people with diabetes or blood pressure for those with heart disease.
In DMD, muscles fail to repair themselves adequately, causing the muscles to degenerate over a few decades. Young boys and men with the disease -- whom DMD hits the most -- usually take steroids to prolong muscle health. Steroids have serious side effects, so patients should only take as much as they need, but it's difficult to monitor effectiveness.
Enter ultrasound. Healthy muscle contains neatly ordered cells, but DMD muscles become fibrous and plum with fat that infiltrates tissue. Because healthy and sick muscles look different in ultrasound images, researchers have been exploring how to use ultrasound to monitor progression of the disease and the muscle's response to drugs.
Previously, researchers, including Hughes, McCarthy and colleagues, have studied mice with genetic mutations that emulate muscular dystrophy. Treating mutant mice with steroids, they found they could process ultrasound information in such a way that they could measure the difference between healthy, damaged and treated muscles -- a method that could put out a number on a screen.
But earlier work required more data than small, hand-held ultrasound gadgets, hooked into a smartphone with a USB cable, would be able to collect. Hughes and McCarthy wanted to know if they could also distinguish between healthy, sick and treated muscles if they collected less than 10 percent of the original data. They turned back to the ultrasound data they had collected on five healthy mice, four afflicted with mouse muscular dystrophy left untreated, and four afflicted but treated with steroids for two weeks.
To use less data, they needed to increase the relevant information in the ultrasound data and downplay the irrelevant background "noise". To do so, they used a mathematical trick called a spline, which smooths the data into average values. With a spline added to their processing program, they re-analyzed either one-eighth or one-sixteenth of the data.
The team found that even with only one-sixteenth of the data, they were able to measure the difference between the treated muscles and the untreated muscles. Of course, people have much larger muscles than mice do, so the researchers would have to adjust the amount of ultrasound data to account for that, but Hughes and McCarthy previously showed that is possible in a different study.
"If we can optimize the processing, we can increase the sensitivity and provide real-time performance," said Hughes. "People with muscular dystrophy have to take the least amount of steroid that will give them the maximum therapeutic effect. This would let them do that."
INFORMATION:
This work was supported by the National Institutes of Health and the National Science Foundation.
Reference: ASA 4aSPa1: Michael Hughes; John McCarthy; Jon Marsh; Samuel Wickline. Optimal smoothing splines improve efficiency of entropy imaging for detection of therapeutic benefit in muscular dystrophy, Thursday, Oct. 30, 9:00 a.m., Marriott Indianapolis Downtown Hotel, Indiana G.
Interdisciplinary teams at Pacific Northwest National Laboratory address many of America's most pressing issues in energy, the environment and national security through advances in basic and applied science. Founded in 1965, PNNL employs 4,300 staff and has an annual budget of about $950 million. It is managed by Battelle for the U.S. Department of Energy's Office of Science. As the single largest supporter of basic research in the physical sciences in the United States, the Office of Science is working to address some of the most pressing challenges of our time. For more information on PNNL, visit the PNNL News Center, or follow PNNL on Facebook, Google+, LinkedIn and Twitter.
WASHINGTON — New research points to tau, not amyloid-beta (Abeta) plaque, as the seminal event that spurs neuron death in disorders such as Alzheimer's disease. The finding, which dramatically alters the prevailing theory of Alzheimer's development, also explains why some people with plaque build-up in their brains don't have dementia.
The study is published online today in the journal Molecular Neurodegeneration.
Neuronal death happens when tau, found inside neurons, fails to function. Tau's role is to provide a structure — like a train track —inside ...
Contrary to popular belief, use of the supplement resveratrol (RSV) may not actually enhance the effects of high-intensity interval training (HIIT).
Many news outlets and health blogs have long recommended RSV as a complement to exercise and to enhance performance. However, results from a study by Queen's researcher Brendon Gurd suggest that RSV may actually impede the body's response to training.
"The easiest way to experience the benefits of physical activity is to be physically active," says Dr. Gurd, a professor in the School of Kinesiology and Health Studies. "The ...
Where does HIV hide? Antiretroviral drugs can usually control the virus, but can't completely eliminate it. So any strategy to eradicate HIV from the body has to take into account not only the main group of immune cells the virus targets, called CD4 or helper T cells, but other infected cells as well.
New research from Yerkes National Primate Research Center, Emory University, sheds light on the question of which cells support viral replication and persistence, and the answers have implications for future efforts to eliminate HIV from the body in human patients.
The ...
The pathogen Giardia duodenalis is present in mussels from freshwater run-off sites and from areas where California Sea Lions lounge along the coast of California, according to a team of researchers from the University of California, Davis. One of the G. duodenalis strains found is known to infect humans; the two others occur mostly in dogs and other canids. "Thus, the detection of these assemblages implies a potential public health risk if consuming fecally contaminated water or uncooked shellfish," says coauthor Woutrina Smith. The research is published ahead of print ...
Today the leading journal PLOS ONE published research that provides underlying scientific support for a fundamentally new type of natural alternative to the use of antibiotics in livestock feeds for growth promotion and disease prevention. The paper is the result of work by both independent and company scientists. Avivagen Inc. is a wellness company developing and delivering products that support and enhance the health and quality of life for animals and the people who care for them.
The discovery that the product formed by full, spontaneous oxidation of beta-carotene, ...
Drug tests on 517 mothers in English inner city hospitals found that nearly 15% had taken recreational drugs during pregnancy and that mothers of babies with birth defects of the brain were significantly more likely to have taken drugs than mothers with normal babies. The study found no significant links between recreational drug use and any other type of birth defect.
The study was led by a team of UCL researchers co-ordinating data collection from hospitals across London, Bristol and Birmingham and the results are published in the journal PLOS ONE. The study included ...
It is up to 30 centimetres long, it has a green-brown color and is probably known to every beach walker on the North and Baltic Sea: the bladderwrack, a seaweed, which is common on the coasts of the whole North Atlantic area. The bladderwrack provides food and habitat for many other organisms. Its abundance is considered to be an indication of whether a coastal ecosystem is intact or not. Especially in the German Baltic Sea, however, the populations have declined considerably in the past decade. The reasons for this are not yet fully known. "Against this background, it ...
Four minutes of physical activity can improve behaviour in the classroom for primary school students, according to new research by Brendon Gurd.
A brief, high-intensity interval exercise, or a "FUNterval," for Grade 2 and Grade 4 students reduced off-task behaviours like fidgeting or inattentiveness in the classroom.
"While 20 minutes of daily physical activity (DPA) is required in Ontario primary schools, there is a need for innovative and accessible ways for teachers to meet this requirement," says Dr. Gurd, lead researcher and professor in the School of Kinesiology ...
In the early 1900s, Brazil was the world's largest producer of cocoa. Chocolate trees (Theobroma cacao) were cultivated in a 800, 000 ha region of rainforest in the state of Bahia, beneath a dense canopy of native shade trees. Whereas the surrounding rainforest was a biodiversity hotspot, the chocolate trees, which were derived mainly from a handful of seeds introduced in the mid 1700s, had very low levels of genetic variation. According to Brazilian scientist Gonçalo Pereira, "This scenario created a very romantic, but extremely fragile situation". Genetic variation ...
In the first study of its kind, Rice University researchers have mapped how information flows through the genetic circuits that cause cancer cells to become metastatic. The research reveals a common pattern in the decision-making that allows cancer cells to both migrate and form new tumors. Researchers say the commonality may open the door to new drugs that interfere with the genetic switches that cancer must flip to form both cancer stem cells and circulating tumor cells -- two of the main players in cancer metastasis.
"Cells have genetic circuits that are used to switch ...
